The main theme of the movie revolves around revealing the reality of the drug companies that tend to test their products on the people of third world countries. These companies do this because they believe they are accountable to no one if any adverse consequences occurred. It is a very serious concern, and there are chances that such types of incidents might have happened in the past and strict regulations are required so that such type of incidents could have been avoided in the future as well. Such types of incidents might occur and are becoming more visible due to the factor of globalisation, and due to this increased connectedness, the vulnerability has also increased more.In response to a question that if such a situation can occur in reality, the verdict of Vioxx is an evident proof where the jury thought that the drug was sold by the company while realising the fact that it is injurious to health. Strict regulations are required to curb such sort of incidents. As far as the safeguards are concerned, it is imperative to gather information about the drug safety. The responsibility lies both in the developing and the developed countries as the strict regulation must be put forward in this regard. There must be a role on an international body in reviewing and allowing the pharmaceutical decisions of the developing country to the developing countries and its conditions where appropriate (Kremer, 2002).A nurse can play a role of health care advocate in this regard. It is one of the basic cannons in the nursing profession and is essential to nursing function. Further, the American Nurses Association Code of Ethics suggests that there must be a commitment by a nurse to advocate for the patients under all conditions and all circumstances (Hanks, 2008). Thus, it becomes a moral duty of a Nurse to stand up in this case and blow the whistle to highlight the concerns which might be injurious to the health of the patient.Works CitedHanks, Robert G. “The lived experience of nursing advocacy.” Nursing Ethics 15.4 (2008): 468-477.Kremer, Michael. “Pharmaceuticals and the developing world.” Journal of Economic Perspectives 16.4 (2002): 67-90.